No parallel relationship between nitric oxide production and wet dog shakes susceptible to nitric oxide synthase inhibitors following systemic administration of paraquat in rats

Archives of Toxicology

Volumn 74, Issue 12, 2001, Pages 775-782

  Hara, Shuichi ^a   Mukai, Toshiji ^b   Kurosaki, Kunihiko ^a   Kuriiwa, Fumi ^a   Yanase, Takeshi ^a   Kano, Sadao ^a   Endo, Takahiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

N Nitro L arginine; Nitric oxide; Paraquat; Rat; Wet dog shakes

Indexed keywords

N(G) NITROARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PARAQUAT; URETHAN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; ELECTROSTIMULATION; ENZYME INHIBITION; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; WET DOG SHAKES;

ANIMALS; ARGININE; BEHAVIOR, ANIMAL; DRUG INTERACTIONS; ENZYME INHIBITORS; HERBICIDES; HIPPOCAMPUS; INJECTIONS, SUBCUTANEOUS; MALE; MICROINJECTIONS; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; NITROARGININE; PARAQUAT; RATS; RATS, SPRAGUE-DAWLEY; REFLEX; TIME FACTORS;

ANIMALIA; CANIS FAMILIARIS;

EID: 0034467645     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040000196     Document Type: Article

References (49)

1. Nitric oxide: Mediator, murderer, and medicine
2. Production of limbic motor seizures and brain damage by systemic and intracerebral injections of paraquat in rats
3. + and paraquat in Rana pipiens
4. Nitric oxide as a mediator of oxidant lung injury due to paraquat
5. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
6. Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
7. Paraquat: Model for oxidant-initiated toxicity
8. Evidence that paraquat is able to cross the blood-brain barrier to a different extent in rats of various age
9. Perspective series: Nitric oxide and nitric oxide synthases. Nitric oxide in excitable tissues: Physiological roles and disease
10. Nitric oxide generators produce accumulation of chelatable zinc in hippocampal neuronal perikarya
11. Hippocampal mediation of shaking behavior induced by electrical stimulation of the perforant path in the rat
12. Nitric oxide and oxygen radicals: A question of balance
13. Behavioural and electrocortical changes induced by paraquat after injection in specific areas of the brain of the rat
14. The glutamate receptor/NO/cyclic GMP pathway in the hippocampus of freely moving rats: Modulation by cyclothiazide, interaction with GABA and the behavioural consequences
15. Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release
16. Convulsions and wet-dog shakes produced by systemic or intrahippocampal administration of ruthenium red in the rat
17. Nitric oxide- and superoxide-mediated toxicity in cerebral endothelial cells
18. Possible catabolism of paraquat in mouse brain microsomes
19. NADPH-dependent reaction of paraquat in mouse brain microsomes
20. Different effects of paraquat on microsomal lipid peroxidation in mouse brain, lung and liver
21. Mechanism of paraquat-stimulated lipid peroxidation in mouse brain and pulmonary microsomes
22. Interaction between dual NADPH-dependent reactions of paraquat in mouse brain microsomes
23. Involvement of opioid receptors in shaking behaviour induced by paraquat in rats
24. Suppression of paraquat-induced wet dog shakes by nitric oxide synthase inhibitors in rats
25. 2+/calmodulin-dependent cytochrome c reductase activity of brain nitric oxide synthase
26. Kainic acid-induced wet clog shakes in rats: The relation to central neurotransmitters
27. MPTP toxicity: Implications for research in Parkinson's disease
28. Immunohistochemical studies on paraquat-induced damage to neuronal and glial cells in rat hippocampus
29. Effects of paraquat on the substantia nigra of the Wistar rats: Neurochemical, histological, and behavioral studies
30. Environmental risk factors and Parkinson's disease: A case-control study in Taiwan
31. Nitric oxide: A physiologic messenger
32. Nitric oxide: Physiology, pathophysiology, and pharmacology
33. Immunohistological localization of paraquat in lung and brain
34. Further evidence that the blood/brain barrier impedes paraquat entry into the brain
35. A novel in vivo assay system for consecutive measurement of brain nitric oxide production combined with the microdialysis technique
36. Evidence for energy-dependent accumulation of paraquat into rat lung
37. Paraquat accumulation: Tissue and species specificity
38. Ex vivo measurement of brain tissue nitrite and nitrate accurately reflects nitric oxide synthase activity in vivo
39. Consecutive in vivo measurement of nitric oxide in transient forebrain ischemic rat under normothermia and hypothermia
40. Consecutive evaluation of nitric oxide production after transient cerebral ischemia in the rat hippocampus using in vivo brain microdialysis
41. Nitric oxide synthase inhibitors: Preclinical studies of potential use for treatment of opioid withdrawal
42. Regional vulnerability to endogenous and exogenous oxidative stress in organotypic hippocampal culture
43. Pharmacological aspects of shaking behavior produced by TRH, AG-3-5, and morphine withdrawal
44. No changes in behaviour, nigro-striatal system neurochemistry or neuronal cell death following toxic multiple oral paraquat administration to rats
45. Neuropeptide Y inhibits hippocampal seizures and wet dog shakes
46. Prevention of DOI-mediated wet dog shakes by inhibitors of nitric oxide synthase
47. Simultaneous measurement of nitrite and nitrate levels as indices of nitric oxide release in the cerebellum of conscious rats
48. Inhibitory effects of calcium channel antagonists on motor dysfunction induced by intracerebroventricular administration of paxaquat